무선 ECG 기기 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the wireless ECG devices market size is expected to grow from USD 5.29 billion in 2025 to USD 5.82 billion in 2026 and is forecast to reach USD 9.38 billion by 2031 at 10.02% CAGR over 2026-2031.

This report is Segmented by Product Type (Monitoring ECG Systems [Remote Data Monitoring, and More] and Diagnostic ECG Systems), Lead Type (Single-Lead, 3-6 Lead and >=12-Lead), End User (Hospitals & Cardiology Clinics, and More), Connectivity (Bluetooth-Only, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Wireless ECG Devices Market Trends and Insights

AI-Enabled Adaptive Compression Lengthens Battery Life

Adaptive compression algorithms reduce wireless data volume by as much as 85% without degrading ECG signal clarity. On-device inference now classifies beat quality in real time and transmits only clinically relevant waveforms, extending operational life from two days to as long as fourteen. This change lowers abandonment rates that previously exceeded 30% in long-term studies. Device makers pair the algorithms with sub-10-µA sleep-mode microcontrollers and advanced lithium-polymer chemistries, bringing multi-lead diagnostic patches into week-long monitoring windows. The technology directly fuels the diagnostic systems segment that is growing at 12.25% CAGR. Battery-life gains also allow hospitals to redeploy staff away from recharging logistics and toward clinical interpretation, tightening total cost of ownership.

Tele-Health Reimbursement Expansion

CMS added remote ECG monitoring to codes 99453-99458 and 99091 in 2024, enabling USD 60-120 in monthly billables per patient episode. Medicaid parity now spans 38 states and most large commercial payers honor similar rates. Providers deploy cellular eSIM devices to satisfy continuous connectivity criteria embedded in the codes. Administrative overhead still rises because each payer enforces unique documentation thresholds, but revenue visibility stabilizes adoption roadmaps for integrated-delivery networks. The reimbursement change underpins the 18.87% CAGR logged by home-based users, a cohort that already reports higher satisfaction scores than in-clinic monitoring.

Complex and Fragmented Reimbursement for RPM Codes

Clinicians juggle multiple codes-99453-99458, 99091, 99490-99491-each demanding different enrollment milestones and review frequencies. Small cardiology practices report two-four hours of monthly paperwork per monitored patient, eroding the economic upside. Variability across state Medicaid programs adds extra layers of checks. Rural providers, already short-staffed, often choose to defer remote ECG initiatives despite device affordability gains. Market participants that offer integrated billing services alongside hardware gain tactical advantage by removing frontline administrative pain points.

Other drivers and restraints analyzed in the detailed report include:

1. Cost Decline of Bluetooth Low-Energy Chipsets
2. China's Class III Domestic Fast-Track for Wearable ECGs
3. Data-Privacy / Cybersecurity Liabilities

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Diagnostic devices generated 12.07% CAGR because providers increasingly prescribe ambulatory 12-lead studies to capture intermittent events. Monitoring systems accounted for 52.12% of the wireless ECG devices market size in 2025 owing to established chronic-care reimbursement. Payers approve extended diagnostic sessions when AI triage keeps cardiologist time under defined thresholds, aligning clinical benefit with cost controls. Players integrate cloud-based algorithms that flag only pathology-suspect intervals, slashing data overload and physician fatigue. Diagnostic patches also gain traction in corporate wellness stress tests, widening addressable demand beyond hospital networks. Meanwhile, monitoring devices retain volume leadership due to routine use in heart-failure programs that mandate daily rhythm checks. Revenue mix therefore tilts toward premium diagnostic platforms even as unit growth remains solid in traditional monitoring.

Enhanced microelectrode arrays allow diagnostic wearables to achieve signal-to-noise ratios once limited to tethered hospital carts. Combined with edge AI packetization, remote 12-lead traces arrive at cardiology dashboards without latency spikes, preventing critical-path delays. Market entrants differentiate with clinician-friendly portals that synthesize weeks' worth of data into color-coded event summaries. These workflow improvements elevate adoption inside community hospitals striving to match tertiary-care standards. Beyond revenue, diagnostic use stabilizes device replacement cycles at higher average selling prices, supporting sustainable R&D budgets that keep the wireless ECG devices market on its innovation trajectory.

Single-lead wearables held 46.05% market share in 2025 because consumer wellness buyers prioritize low cost and ease of use. However, >= 12-lead solutions are compounding at 13.72% on the strength of clinical indispensability in ischemia and complex arrhythmia detection. Payers increasingly reimburse multi-lead ambulatory studies once traditional Holter loops miss transient pathologies, solidifying the premium tier. Vendors offset higher component counts with modular board designs and shared firmware stacks that streamline regulatory change-control filings. Algorithm vendors supply vector-reconstruction engines that extract additional leads mathematically, yet cardiologists still favor true hardware-based multi-lead fidelity for actionable diagnosis.

Lead-count choice also shapes service-level agreements. Hospitals negotiate uptime commitments measured in diagnostic-grade minutes, making redundant-lead grids attractive for compliance. In direct consumer channels, single-lead models adopt auto-referral features that nudge users toward clinical consults, thereby feeding multi-lead product pipelines. The resulting segmentation keeps both price points viable but shifts profit pools toward multi-lead innovators with proprietary signal-processing IP. Unit economics improve further when cloud storage moves to tiered retention plans, enabling differentiated subscription tiers that monetize multi-lead data richness.

Complete Report Scope:

• By Product Type
  • Monitoring ECG Systems
    • Remote Data Monitoring
    • Event Monitoring
    • Continuous Monitoring Systems
  • Diagnostic ECG Systems
    • Rest ECG Systems
    • Stress ECG Systems
    • Holter ECG Systems
• By Lead Type
  • Single-lead
  • 3-6 lead
  • Greater Than 12-lead
• By End User
  • Hospitals & Cardiology Clinics
  • Home-based Users
  • Ambulatory Surgical & Diagnostic Centers
• By Connectivity
  • Bluetooth-only
  • Cellular / eSIM-enabled
  • Hybrid (BLE + Cellular)
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America retained 41.10% of revenue in 2025, supported by mature hospital telemetry infrastructure, but CAGRs taper as saturation rises and administrative billing burden persists. The wireless ECG devices market remains steady because payer incentives still favor readmission reduction, yet smaller practices slow rollouts until coding clarity improves. Canada pilots nationwide RPM reimbursement in cardiology, mirroring early U.S. models but leveraging single-payer efficiencies. Mexico's social-security system tests subsidized patches in rural clinics, aiming to extend specialist reach across underserved areas.

Asia-Pacific grows at a brisk 15.61% CAGR, anchored by China's policy tailwinds and manufacturing self-reliance. NMPA fast-track approvals shorten commercialization cycles, inviting rapid iteration and local price drops. Japan's super-aged society drives continuous monitoring adoption in home-nursing programs, while South Korea pairs 5G infrastructure with AI triage engines to streamline cardiology consult queues. India gains momentum through public-private partnerships that combine low-cost devices with community health workers, although infrastructure variability keeps uptake uneven across states. Australia and Southeast Asian nations leverage remote-area grants to supply wearables in indigenous and island communities, validating export potential for ruggedized designs.

Europe sits between mature and growth profiles. Northern markets integrate ECG telemetry into long-term disease-management budgets, whereas Southern regions prioritize cost containment but trial low-lead patches for high-risk groups. GDPR compliance pushes vendors to host data inside EU borders, shaping procurement towards suppliers with in-region cloud partners. Germany's statutory insurers reimburse diagnostic patches once physician associations ratify workflow guidelines, raising baseline demand. The United Kingdom-post-Brexit-aligns its approval timings with MHRA processes that run parallel to FDA pathways, giving local startups a domestic launch pad. Outside the triad, Latin America and the Middle East start small pilots, usually grant-financed, signaling future demand once infrastructure and purchasing power converge.

1. Abbott Laboratories
2. Aerotel Medical Systems
3. AliveCor
4. Apple
5. Bittium Corporation
6. CardioComm Solutions
7. Contec Medical Systems
8. GE Healthcare
9. iRhythm Technologies
10. Medtronic
11. Nihon Kohden
12. Koninklijke Philips
13. Preventice (Boston Scientific)
14. Qardio Inc.
15. Schiller
16. Vital Connect
17. Withings
18. ZOLL Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Geriatric Population & CVD Prevalence
  • 4.2.2 Tele-Health Reimbursement Expansion
  • 4.2.3 Cost Decline of Bluetooth Low-Energy Chipsets
  • 4.2.4 AI-Enabled Adaptive Compression Lengthens Battery Life
  • 4.2.5 China's Class III Domestic Fast-Track for Wearable ECGs
  • 4.2.6 Employer-Funded Cardiac-Wellness Programs
• 4.3 Market Restraints
  • 4.3.1 Complex & Fragmented Reimbursement for RPM Codes
  • 4.3.2 Data-Privacy / Cybersecurity Liabilities
  • 4.3.3 Dry-Electrode Dermatitis Driving Patch Abandon-Rates
  • 4.3.4 2025 US Tariff Surge on Medical Electronics Sub-Assemblies
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Monitoring ECG Systems
    • 5.1.1.1 Remote Data Monitoring
    • 5.1.1.2 Event Monitoring
    • 5.1.1.3 Continuous Monitoring Systems
  • 5.1.2 Diagnostic ECG Systems
    • 5.1.2.1 Rest ECG Systems
    • 5.1.2.2 Stress ECG Systems
    • 5.1.2.3 Holter ECG Systems
• 5.2 By Lead Type
  • 5.2.1 Single-lead
  • 5.2.2 3-6 lead
  • 5.2.3 Greater Than 12-lead
• 5.3 By End User
  • 5.3.1 Hospitals & Cardiology Clinics
  • 5.3.2 Home-based Users
  • 5.3.3 Ambulatory Surgical & Diagnostic Centers
• 5.4 By Connectivity
  • 5.4.1 Bluetooth-only
  • 5.4.2 Cellular / eSIM-enabled
  • 5.4.3 Hybrid (BLE + Cellular)
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 Abbott Laboratories
  • 6.3.2 Aerotel Medical Systems
  • 6.3.3 AliveCor
  • 6.3.4 Apple Inc.
  • 6.3.5 Bittium Corporation
  • 6.3.6 CardioComm Solutions
  • 6.3.7 Contec Medical Systems
  • 6.3.8 GE Healthcare
  • 6.3.9 iRhythm Technologies
  • 6.3.10 Medtronic PLC
  • 6.3.11 Nihon Kohden
  • 6.3.12 Philips Healthcare
  • 6.3.13 Preventice (Boston Scientific)
  • 6.3.14 Qardio Inc.
  • 6.3.15 Schiller AG
  • 6.3.16 VitalConnect
  • 6.3.17 Withings
  • 6.3.18 ZOLL Medical

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment